-- 独立研究机构CFRA向提供了以下研究报告。CFRA分析师的观点总结如下： O公司公布了强劲的第一季度业绩，营收达15.5亿美元，同比增长12.2%，高于去年同期的13.8亿美元。其中，租赁收入达14.4亿美元，同比增长9.7%，超出市场预期4700万美元。同店租赁收入同比增长0.8%至11.9亿美元，尽管由于物业费用增加，营业利润率下降70个基点至89.7%，但调整后EBITDA仍同比增长10.2%至13.9亿美元。续租物业的租金回收率依然强劲，达到103.4%，这表明O公司在其多元化的物业组合中，在续租时仍能保持强大的定价能力。本季度，O公司签署了301份租赁协议，其中264份续租给现有客户，37份出租给新客户。同时，作为其投资组合优化战略的一部分，O公司积极出售了97处房产，总价值达1.88亿美元。两位数的稳健营收增长、超过100%的强劲租金回收率以及积极的租赁活动，共同体现了O公司在三方净租赁领域的持续卓越运营和市场领先地位。
Related Articles
Asia
StarHub's Net Attributable Profit Falls 81% in Q1
StarHub's (SGX:CC3) net attributable profit to shareholders plunged 81% in the first quarter of the year to SG$5.9 million from SG$31.8 million a year earlier, according to a Thursday filing with the Singapore Exchange.Revenue declined 6.1% year over year to SG$507.3 million from SG$540.5 million, mainly due to an across-the-board decline in services revenue.
$SGX:CC3
Asia
Meesho Narrows Consolidated Loss in Fiscal Q4
Meesho (NSE:MEESHO, BOM:544632) narrowed its consolidated attributable loss to 1.66 billion Indian rupees in the fiscal fourth quarter ended March 31, from a loss of 13.9 billion rupees a year ago.Loss per share contracted to 0.36 rupees from a loss per share of 3.39 rupees a year earlier, the online marketplace said in a filing to the Indian stock exchanges on Wednesday. The loss per share was lower than the 0.73 rupees estimated by the analysts polled by Visible Alpha.Revenue from operations in fiscal Q4 increased to 35.3 billion rupees from 24.0 billion rupees a year ago. This is a tad higher than Visible Alpha's estimate of 35.2 billion rupees a year ago.
$BOM:544632$NSE:MEESHO
Asia
Changchun High-Tech Gets Regulatory Nod for Gouty Arthritis Drug
Changchun High-Tech Industry (SHE:000661) subsidiary Changchun Genescience Pharmaceutical obtained China's regulatory approval to manufacture and market its fuxinqibai monoclonal antibody injection.The drug is indicated for acute gouty arthritis attacks in adults poorly responsive to standard therapies, according to a Thursday filing with the Shenzhen bourse.
$SHE:000661